Skip to main content
SpringerLink
Log in

Single nucleotide polymorphisms and colorectal neoplasia risk: Updates and impact

  • Published:
Current Colorectal Cancer Reports

Abstract

Polymorphisms in genes related to various endogenous pathways (eg, metabolic, detoxification, and DNA repair) have been linked to colorectal cancer risk. To date, much of the literature has focused on the study of single nucleotide polymorphisms (SNPs) in DNA repair pathways (eg, base excision repair and nucleotide excision repair). Over the past years, SNPs within known cancer risk loci and in pathways related to one-carbon metabolism, inflammation or inflammatory mediators, and leptin signaling (among others) have expanded our understanding of how polymorphic variation across several genes and pathways influences disease risk. Work from our group explores how variants of the adenomatous polyposis coli (APC) gene and the CD24 gene impact colorectal neoplasia risk. Despite brisk research in this area, clinical applicability remains limited. This article includes an up-to-date review (2007-present) of several studies examining polymorphisms and colorectal neoplasia risk, a discussion of recent findings in the assessment of colorectal neoplasia risk associated with the APC I1307K and E1317Q variants from our group, and finally a brief assessment of the impact of polymorphism research on clinical practice to date.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Gryfe R: Clinical implications of our advancing knowledge of colorectal cancer genetics: inherited syndromes, prognosis, prevention, screening and therapeutics. Surg Clin North Am 2006, 86:787–817.

    Article  PubMed  Google Scholar 

  2. Rustgi AK: The genetics of hereditary colorectal cancer. Genes Dev 2007, 21:2525–2538.

    Article  PubMed  CAS  Google Scholar 

  3. Houlston RS, Tomlinson IP: Polymorphisms and colorectal tumor risk. Gastroenterology 2001, 121:282–301.

    Article  PubMed  CAS  Google Scholar 

  4. Naccarati A, Pardini B, Hemminki K, Vodicka P: Sporadic colorectal cancer and individual susceptibility: a review of the association studies investigating the role of DNA repair genetic polymorphisms. Mutat Res 2007, 635:118–145.

    Article  PubMed  CAS  Google Scholar 

  5. Tomlinson IPM, Webb E, Carvajal-Carmona L, et al.: A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Gen 2008, 40:623–630.

    Article  CAS  Google Scholar 

  6. Jung AY, Poole EM, Bigler J, et al.: DNA methyltransferase and alcohol dehydrogenase: gene nutrient interactions in relation to risk of colorectal polyps. Cancer Epidemiol Biomarkers Prev 2008, 17:330–338.

    Article  PubMed  CAS  Google Scholar 

  7. Hazra A, Wu K, Kraft P, et al.: Twenty-four non-synonymous polymorphism in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses’ Health Study. Carcinogenesis 2007, 28:1510–1519.

    Article  PubMed  CAS  Google Scholar 

  8. Hubner RA, Liu JF, Sellick GS, et al.: Thymidylate synthase polymorphisms, folate and B-vitamin intake and risk of colorectal adenoma. Br J Cancer 2007, 97:1449–1456.

    Article  PubMed  CAS  Google Scholar 

  9. Chia VM, Newcomb PA, Lampe JW, et al.: Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2007, 16:2697–2703.

    Article  PubMed  CAS  Google Scholar 

  10. Arber N, Eagle CJ, Spicak J, et al.: Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006, 355:885–895.

    Article  PubMed  CAS  Google Scholar 

  11. Baron JA, Cole BF, Sandler RS, et al.: A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003, 348:891–899.

    Article  PubMed  CAS  Google Scholar 

  12. Dube C, Rostom A, Lewin G, et al.: The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 2007, 146:365–375.

    PubMed  Google Scholar 

  13. Sandler RS, Halabi S, Baron JA, et al.: A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003, 248:883–890. [Published erratum appears in N Engl J Med 2003, 348:1939.]

    Article  Google Scholar 

  14. Hubner RA, Muir KR, Liu JF, et al.: Ornithine decarboxylase G316A genotype is prognostic for colorectal adenoma recurrence and predicts efficacy of aspirin chemoprevention. Clin Cancer Res 2008, 14:2303–2309.

    Article  PubMed  CAS  Google Scholar 

  15. Barry EL, Baron JA, Bhat S, et al.: Ornithine decarboxylase polymorphism modification of response to aspirin for colorectal adenoma prevention. J Natl Cancer Inst 2006, 98:1494–1500.

    Article  PubMed  CAS  Google Scholar 

  16. Martinez ME, O’Brien TG, Fultz KE, et al.: Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proc Natl Acad Sci U S A 2007, 100:7859–7864.

    Article  CAS  Google Scholar 

  17. Gong Z, Hebert JR, Bostick RM, et al.: Common polymorphisms in the 5-lipoxygenase and 12-lipoxygenase genes and the risk of incident, sporadic colorectal adenoma. Cancer 2007, 109:849–857.

    Article  PubMed  CAS  Google Scholar 

  18. Landi S, Bottari F, Gemignani F, et al.: Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk. Eur J Cancer 2007, 43:762–768.

    Article  PubMed  CAS  Google Scholar 

  19. Stern MC, Siegmund KD, Conti DV, et al.: XRCC1, XRCC3 and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2007, 15:2384–2389.

    Article  Google Scholar 

  20. Stern MC, Siegmund KD, Corral R, et al.: XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2005, 14:609–615.

    Article  PubMed  CAS  Google Scholar 

  21. Skjelbred CF, Saebo M, Wallin H, et al.: Polymorphisms of the XRCC1, XRCC3, and XPD genes and risk of colorectal adenoma and carcinoma in a Norwegian cohort: a case control study. BMC Cancer 2006, 6:67.

    Article  PubMed  CAS  Google Scholar 

  22. Goodman JE, Mechanic LE, Luke BT, et al.: Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis. Int J Cancer. 2006, 118:1790–1797.

    Article  PubMed  CAS  Google Scholar 

  23. Hong YC, Lee KH, Kim WC, et al.: Polymorphisms of XRCC1 gene, alcohol consumption and colorectal cancer. Int J Cancer 2005, 116:428–432.

    Article  PubMed  CAS  Google Scholar 

  24. Krupa R, Blasiak J: An association of polymorphisms of DNA repair genes XRCC1 and XRCC3 with colorectal cancer. J Exp Clin Can Res 2004, 23:285–294.

    CAS  Google Scholar 

  25. Moreno V, Gemignani F, Landi S, et al.: Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res 2006, 12(7 Pt 1):2101–2108.

    Article  PubMed  CAS  Google Scholar 

  26. Yeh CC, Sung FC, Tang R, et al.: Polymorphisms of the XRCC1, XRCC3, and XPD genes, and colorectal cancer risk: a case control study in Taiwan. BMC Cancer 2005, 5:12.

    Article  PubMed  CAS  Google Scholar 

  27. Gao R, Price DK, Sissung T, et al.: Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1 ERCC2, XRCC1 and PARP1. Mol Cancer Ther 2008, 7:1246–1250.

    Article  PubMed  CAS  Google Scholar 

  28. Berndt SI, Huang WY, Fallin MD, et al.: Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma. Cancer Res 2007, 67:1395–1404.

    Article  PubMed  CAS  Google Scholar 

  29. Wisniewska-Jarosinska MA, Sliwinski T, Lech J, et al.: Polymorphisms of the DNA repair genes Rad51, Xrcc2, Xrcc3 in inflammatory bowel disease and colorectal cancer [abstract 918]. Presented at Digestive Diseases Week. Orlando, FL: May 19–23, 2008.

  30. Vogelstein B, Fearon ER, Hamilton SR, et al.: Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319:525–532.

    PubMed  CAS  Google Scholar 

  31. Jaeger E, Webb E, Howarth K, et al.: Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Gen 2008, 40:26–28.

    Article  CAS  Google Scholar 

  32. de la Chapelle A: Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004, 4:769–80.

    Article  PubMed  CAS  Google Scholar 

  33. Laken SJ, Petersen GM, Gruber SB, et al.: Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.Nat Genet 1997, 17:79–83.

    Article  PubMed  CAS  Google Scholar 

  34. Syngal S, Schrag D, Falchuk M, et al.: Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps. JAMA 2000, 284:857–860.

    Article  PubMed  CAS  Google Scholar 

  35. Rennert G, Almog R, Tomsho LP, et al.: Colorectal polyps in carriers of the APC I1307K polymorphism. Dis Colon Rectum 2005, 48:2317–2321.

    Article  PubMed  Google Scholar 

  36. Gryfe R, Di Nicola N, Lal G, et al.: Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet 1999, 64:378–384.

    Article  PubMed  CAS  Google Scholar 

  37. Figer A, Irmin L, Geva R, et al.: Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer. Br J Cancer 2001, 85:523–526.

    Article  PubMed  CAS  Google Scholar 

  38. Drucker L, Shpilberg O, Neumann A, et al.: Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype. Cancer 2000, 88:755–760.

    Article  PubMed  CAS  Google Scholar 

  39. White S, Bubb VJ, Wyllie AH: Germline APC mutation (Gln1317) in a cancer-prone family that does not result in familial adenomatous polyposis. Genes Chromosomes Cancer 1996, 15:122–128.

    Article  PubMed  CAS  Google Scholar 

  40. Lamlum H, Al Tassan N, Jaeger E, et al.: Germline APC variants in individuals with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum Molec Genet 2000, 9:2215–2221.

    PubMed  CAS  Google Scholar 

  41. Hahnloser D, Petersen GM, Rabe K, et al.: The APC E1317Q variant in adenomatous polyps and colorectal cancers. Cancer Epidemiol Biomarkers Prev 2003, 12:1023–1028.

    PubMed  CAS  Google Scholar 

  42. Popat S, Stone J, Coleman G, et al.: Prevalence of the APC E1317Q variant in colorectal cancer patients. Cancer Lett 2000, 149:203–206.

    Article  PubMed  CAS  Google Scholar 

  43. Fearnhead NS, Wilding JL, Winney B, et al.: Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci U S A 2004, 101:15992–15997.

    Article  PubMed  CAS  Google Scholar 

  44. Rozek LS, Rennert G, Gruber SB: APC E1317Q is not associated with colorectal cancer in a population-based case-control study in northern Israel. Cancer Epidemiol Biomarkers Prev 2006, 15:2325–2327.

    Article  PubMed  CAS  Google Scholar 

  45. Hall MJ, Liberman E, Dulcrate O, et al.: Gene-gene interactions and the risk of colorectal neoplasia associated with variants of the APC and CD24 genes. Presented at Digestive Disease Week. San Diego, CA: May 17–22, 2008.

  46. Dolkart O, Hall MJ, Liberman E, et al.: Increased risk of colorectal neoplasia associated with the E1317Q variant of APC and the potential for risk modification by other genetic loci. Presented at Digestive Disease Week. Washington DC: May 20–24, 2007.

  47. Sagiv E, Starr A, Rozovski U, et al.: Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies of small interfering RNA. Cancer Res 2008, 68:2803–2812.

    Article  PubMed  CAS  Google Scholar 

  48. Fidder HH, Figer A, Geva R, et al.: Genetic analyses in consecutive Israeli Jewish colorectal cancer patients. Am J Gastroenterol 2005, 100:1376–1380.

    Article  PubMed  CAS  Google Scholar 

  49. Regev M, Barzilai SE, Figer A, et al.: The I1307K APC mutation in a high-risk clinic setting: a follow-up study. Clin Genet 2005, 67:352–355.

    Article  PubMed  CAS  Google Scholar 

  50. Bernig T, Chanock SJ: Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer. Expert Rev Mol Diagn 2006, 6:319–331.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fox Chase Cancer Center, Gastrointestinal Tumor Risk Assessment Program, 333 Cottman Avenue, Philadelphia, PA, 19111, USA

    Michael J. Hall

Authors
  1. Michael J. Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J. Hall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hall, M.J. Single nucleotide polymorphisms and colorectal neoplasia risk: Updates and impact. Curr colorectal cancer rep 5, 15–23 (2009). https://doi.org/10.1007/s11888-009-0003-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11888-009-0003-z

Keywords

Search

Navigation